S11 Ep14: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS
In this episode of The Midweek Takeaway, Phil Carroll and Kevin Hornsby speak with Anthony Tennyson, CEO of Solvonis Therapeutics (LSE: SVNS), about the company’s strengthened leadership following the appointment of Paul Carter, former Gilead CCO, and its progress across key CNS programmes. Anthony outlines Solvonis’ licensing-first, capital-efficient model and updates on SVN-001 for alcohol use disorder, SVN-002 for the US market, and SVN-SDN-14 targeting PTSD — reflecting Solvonis’ mission to advance next-generation treatments for addiction and mental health.
Disclaimer & Declaration of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.